Results 211 to 220 of about 34,165 (229)

ANTI-CD39 ANTIBODY

2023
NAKAMURA NORIHIRO, MIE MOTOYA, OBONAI TOSHIFUMI, BAN HARUKA, MATSUMOTO NORIKO, SHIRAISHI MAMORU, MATSUMURA HARUKA   +6 more
openaire   +1 more source

A Single-Chain Antibody-CD39 Fusion Protein Targeting Activated Platelets Protects From Cardiac Ischaemia/Reperfusion Injury.

European Heart Journal, 2018
Xiaowei Wang, Melanie Ziegler, Karlheinz Peter   +2 more
exaly  

Anti-CD39 antibodies and use thereof

2023
BOWMAN CHRISTINE ELIZABETH, CHEN ADA PEI XIAN, FERNANDEZ-SALAS ESTER, WALKER NIGEL PELHAM CLINTON, ZHAO XIAONING, HU YAOHUA, NIE SIWEI, GU JIJIE   +7 more
openaire   +3 more sources

The Role of NK Cells and CD39 in the Immunological Control of Tumor Metastases

OncoImmunology, 2019
Simon C. Robson, Mark J. Smyth, Michele W.L. Teng   +2 more
exaly  

Phenotypic and Functional Characteristics of CD4+CD39+ FOXP3+ and CD4+CD39+FOXP3neg T-Cell Subsets in Cancer Patients

European Journal of Immunology, 2012
Theresa L. Whiteside, Bastian Schilling, Patrick J Schüler   +2 more
exaly  

Antisense to Human CD39 Dysregulates Immune Metabolism in Inflammatory Bowel Disease

Cellular and Molecular Immunology
Satya Keerthi Kota, Maria Serena Longhi, Guanqing Chen   +2 more
exaly  

Altered CD39 and CD73 Expression in Rheumatoid Arthritis: Implications for Disease Activity and Treatment Response

Biomolecules
Diaz-Torne Cesar, Maria Àngels Ortiz, Sílvia Vidal   +2 more
exaly  

IL-27 Confers a Protumorigenic Activity of Regulatory T Cells via CD39

Proceedings of the National Academy of Sciences of the United States of America, 2019
Yeonseok Chung, Eun Sook Hwang, Heeju Ryu   +2 more
exaly  

CD39 Transforming Cancer Therapy by Modulating Tumor Microenvironment

Cancer Letters
Wenxue Ma, Qingqing Wang, Suling Xu
exaly  

ANTI-CD39 ANTIBODIES

2018
GAUTHIER LAURENT, ROUSSEL ALAIN, AMIGUES BÉATRICE   +2 more
openaire   +1 more source